Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank50
3Y CAGR-35.1%
5Y CAGR+152.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-35.1%/yr
vs +224.9%/yr prior
5Y CAGR
+152.9%/yr
Recent deceleration
Acceleration
-260.0pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
103.4x
Strong expansion
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -48.0% |
| 2024 | 0.04 | -22.8% |
| 2023 | 0.05 | -31.8% |
| 2022 | 0.07 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 0.00 | -68.9% |
| 2019 | 0.00 | -5.2% |
| 2018 | 0.00 | -100.0% |
| 2017 | 26.16 | - |